Gary Naglie, MD, MSc

Clinical Researcher,
Geriatric Medicine Research
Toronto Rehabilitation Institute

Gary Naglie is a staff geriatrician at the University Health Network (UHN) and the Toronto Rehabilitation Institute (TRI). He is the first holder of the Mary Trimmer Chair in Geriatric Medicine Research, University of Toronto. He is a senior scientist at the Toronto General Research Institute, Division of Clinical Decision Making and Health Care Research and at the Toronto Rehabilitation Institute, Associate Professor in the Departments of Medicine and Health Policy, Management and Evaluation and Graduate Faculty Member at the Institute of Medical Science (IMS), Faculty of Medicine, University of Toronto.

Naglie’s research focuses on outcome evaluation in frail older populations, including older adults with dementia, Parkinson’s disease, end-stage renal failure on dialysis, prostate cancer and hip fractures. He has a particular interest in program evaluation and establishing appropriate measures for outcome assessment in the frail elderly. Naglie is currently funded by CIHR and Alzheimer Society of Canada to lead a national study on assessing quality of life in patients with Alzheimer’s disease and their caregivers. He is also working with a multidisciplinary team to assess the barriers to exercise in older dialysis patients and to develop an individual exercise program to promote greater physical activity in these patients.

Telephone: 416-597-3422, ext. 3834
Naglie.Gary@torontorehab.on.ca

Selected Publications

  • Gagnon N, Flint AJ, Naglie G, Devins GM. Affective correlates of fear of falling in the elderly. American Journal of Geriatric Psychiatry. 2005; 13:7-14.
  • Wodchis W, Teare GF, Naglie G, Bronskill S, Gill SS, Hillmer MP, Anderson GM, Rochon PA, Fries BE. Skilled nursing facility rehabilitation and discharge to home following stroke. Archives of Physical Medicine and Rehabilitation. 2005; 86:442-448.
  • Ritvo P, Irvine J, Naglie G, Tomlinson G, Bezjak A, Matthew A, Trachtenberg J, Krahn M. Reliability and validity of the PORPUS, a combined psychometric and utility-based quality of life instrument for prostate cancer. Journal of Clinical Epidemiology. 2005; 58:466-474.
  • Alibhai SMH, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G. Is there age bias in the treatment of localized prostate cancer? Cancer. 2004; 100:72-81.
  • Marras C, Lang A, Krahn M, Tomlinson G, Naglie G, Parkinson Study Group. Quality of life impact of motor complications of dopaminergic therapy in early Parkinson’s disease. Movement Disorders. 2004; 19:22-28.
  • Hogan DB, Goldlist B, Naglie G, Patterson C. Comparison studies of cholinesterase inhibitors for Alzheimer’s disease. Lancet Neurology. 2004; 3:622-626.

See publications by Gary Naglie on PubMed.